Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer

Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer

The mainstay treatment for patients with immediate resectable pancreatic cancer remains upfront surgery, which represents the only potentially curative strategy. Nevertheless, the majority of patients surgically resected for pancreatic cancer experiences disease relapse, even when a combination adju...

Full description

Bibliographic Details
Main Authors: Valeria Merz, Domenico Mangiameli, Camilla Zecchetto, Alberto Quinzii, Silvia Pietrobono, Carlo Messina, Simona Casalino, Marina Gaule, Camilla Pesoni, Pasquale Vitale, Chiara Trentin, Michela Frisinghelli, Orazio Caffo, Davide Melisi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Surgery
Subjects:
resectable pancreatic cancer
predictive factors
neoadjuvant therapy
preoperative treatment
target therapy
molecular profiling
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.866173/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2022.866173/full

Similar Items